| Next 10 |
Ad
CNTB News and Press Connect Biopharma Holdings Limited
News | Connect Biopharma Holdings Limited (NASDAQ:CNTB)
-
2025-04-15 18:49:03 ET Connect Biopharma Holdings Limited (CNTB) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 5.67%. The average open to low on the day of earnings was -6.14%. The ave...
-
2025-04-15 18:44:03 ET Connect Biopharma Holdings Limited (CNTB) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in CNTB stock price following earnings has averaged ±14.09% , with a media...
-
United Airlines Holdings Inc. (UAL) is expected to report $0.8 for Q1 2025 Bank First Corporation (BFC) is expected to report $1.62 for Q1 2025 Interactive Brokers Group Inc. (IBKR) is expected to report $1.91 for Q1 2025 Bank of America Corporation (BAC) is expected to report $0.81 f...
-
2025-03-28 16:17:41 ET Read the full article on Seeking Alpha For further details see: Connect Biopharma receives Nasdaq non-compliance notice
-
SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care in Asthma and Chronic Obstructive Pulmonary...
-
FREMONT, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Attovia Therapeutics announced the appointment of Steven Chan as Chief Financial Officer. Mr. Chan brings extensive financial strategy and operational experience and joins Attovia after serving as Chief Financial Officer at Connect Biopharma (NAS...
-
SAN DIEGO, CA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma,” “Connect” or the “Company”), a U.S.-headquartered global clinical-stage biopharmaceutical company dedicated to improving the lives of...
-
2024-09-08 05:01:00 ET Summary EpimAb Biotherapeutics sold global (ex-China) rights for a clinical-stage asset to Vignette Bio, a San Francisco startup, in a $635 million deal. TargetRx raised $20 million by selling China commercial rights for an ALK inhibitor to Nanjing’s ...
-
2024-09-05 16:31:41 ET More on Connect Biopharma Seeking Alpha’s Quant Rating on Connect Biopharma Historical earnings data for Connect Biopharma Financial information for Connect Biopharma Read the full article on Seeking Alpha For further det...
-
Announced new U.S.-based leadership with the appointment of Barry Quart, Pharm.D. as Chief Executive Officer (CEO) and David Szekeres as President Connect’s new management is currently evaluating the future clinical development strategy for rademikibart As part of Connect’s ...
Stock Information
Get CNTB Alerts
News, Short Squeeze, Breakout and More Instantly...
Connect Biopharma Holdings Limited Company Name:
CNTB Stock Symbol:
NASDAQ Market:
0.45% G/L:
$0.781 Last:
87,213 Volume:
$0.77 Open:
$0.781 Close:
Connect Biopharma Holdings Limited Website:
Ad
-
2025-04-15 18:49:03 ET Connect Biopharma Holdings Limited (CNTB) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 5.67%. The average open to low on the day of earnings was -6.14%. The ave...
-
2025-04-15 18:44:03 ET Connect Biopharma Holdings Limited (CNTB) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in CNTB stock price following earnings has averaged ±14.09% , with a media...
-
United Airlines Holdings Inc. (UAL) is expected to report $0.8 for Q1 2025 Bank First Corporation (BFC) is expected to report $1.62 for Q1 2025 Interactive Brokers Group Inc. (IBKR) is expected to report $1.91 for Q1 2025 Bank of America Corporation (BAC) is expected to report $0.81 f...